Navigation Links
Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
Date:1/24/2008

oblem.

About Multiple Myeloma

Multiple myeloma (also known as myeloma or plasma cell myeloma) is a cancer of the blood in which malignant plasma cells are overproduced in the bone marrow. Plasma cells are white blood cells that help produce antibodies called immunoglobulins that fight infection and disease. However, most patients with multiple myeloma have cells that produce a form of immunoglobulin called paraprotein (or M protein) that does not benefit the body. In addition, the malignant plasma cells replace normal plasma cells and other white blood cells important to the immune system. Multiple myeloma cells can also attach to other tissues of the body, such as bone, and produce tumors. The cause of the disease is unknown.

About Pharmion

Pharmion is a leading global oncology company uniquely focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

References

1. Facon Thierry, et al. Superiority of Melphalan and Prednisone

chemotherapy plus Thalidomide over Melphalan and Prednisone alone or

reduced-intensity autologous stem cell transplantation in elderly

patients with multiple myeloma: Results of a randomised IFM trial. The

Lancet Vol 370 October 6, 2007, pp 1209-1217

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on current expectations and involve a number of known and unknown ri
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
3. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
4. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
5. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
6. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
7. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
8. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
9. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
11. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... of the "Medical Device Outsourcing - Global ... This report analyzes the worldwide markets ... the following Device Categories: Class I, Class II, ... in the report Include - Radiology, Orthopedic, Neurology, ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... ConvaTec, a world-leading developer and marketer ... today announced that Amcare Ltd, a wholly-owned subsidiary of ... (operating as "Trent Direct"), a UK-based company that specialises ... continence care products. As a well-respected ...
... BIRMINGHAM, Ala., June 1, 2011 DST Health Solutions, ... which provides transparent access to strategic operational data by ... industry-first, 3i offers DST Health Solutions customers the ability ... flags issues requiring immediate attention. DST Health Solutions has ...
Cached Medicine Technology:ConvaTec Announces Acquisition of Trent Direct 2DST Health Solutions' iPad® App Helps Improve Efficiency of Claims Administration With Real-Time Alerts 2DST Health Solutions' iPad® App Helps Improve Efficiency of Claims Administration With Real-Time Alerts 3
(Date:4/19/2015)... April 19, 2015 Indiana Fiber ... Service Provider, announces a major bandwidth upgrade infrastructure ... Bluffton, IN. Craigville Telephone Company, Inc. (DBA ... service on IFN’s protected 10 Gigabit internet transport ... Vice President of Sales and Marketing, AdamsWells expanded ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancehints.com has released ... insurance plans that offer financial protection against fire damage. ... will pay benefits in case their vehicle is set intentionally ... vandalism caused by rioting or by other things. , ... quotes on a single website http://www.carinsurancehints.com/ , in ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post ... . , Clients can review important auto insurance ... environment provides important advantages for clients who need affordable ... do not have coverage for their vehicles can purchase ... or hour. Many agencies offer important discounts and drivers ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Thousand of ... on behalf of individuals who were allegedly harmed by ... to move forward in the U.S. District Court, Northern ... 10th, the Court has amended an earlier Case Management ... Among other things, the new amendment permits the claims ...
Breaking Medicine News(10 mins):Health News:AdamsWells Internet Telecom TV Expands Bandwidth via Indiana Fiber Network, LLC 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
... WASHINGTON A new report from the National Research ... and Drug Administration to systematically evaluate and compare the ... variety of products. Moreover, the risk-assessment framework provides ... draws extensively on well-vetted risk literature to define the ...
... their lungs similar to that suffered by smokers who have ... of a new study, led by Catalan researchers, which confirms ... "Our objective was to analyse the expression of a ... with COPD, whether smokers or not, and people who had ...
... Association (AGA) honors several individuals for their outstanding contributions ... "The AGA recognition award recipients are individuals who ... highest level of esteem and confidence from their peers," ... the AGA Institute. "The AGA is honored to have ...
... -- People at risk for celiac disease ought to be ... a new study suggests. Celiac disease is a disorder ... person consumes gluten, a protein found in wheat, rye and ... grown rapidly in recent decades, but, according to the study ...
... of cancer compared with heterosexual men, and lesbian and ... than heterosexual female cancer survivors. Those are the conclusions ... Cancer , a peer-reviewed journal of the American Cancer ... of programs and services that are needed to assist ...
... SUNDAY, May 8 (HealthDay News) -- Celiac disease is more ... according to a new study from the Massachusetts General Hospital ... incidence of this autoimmune disease may be related to a ... is a digestive disorder triggered by consuming the protein gluten, ...
Cached Medicine News:Health News:FDA could analyze public health consequences of its decisions better 2Health News:Smokers undergo the same changes in gene expression as patients with COPD 2Health News:AGA announces prestigious recognition award recipients 2Health News:AGA announces prestigious recognition award recipients 3Health News:AGA announces prestigious recognition award recipients 4Health News:More People May Benefit From Going Gluten-Free 2Health News:Sexual orientation affects cancer survivorship 2Health News:Kids' Birth Month Seems to Be Linked to Celiac Disease: Study 2
... is the most potent glucocorticoid produced ... plasma, most cortisol is bound with ... with the remainder loosely bound to ... receptors with effects in numerous physiologic ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... Insulin-like growth factor I (IGF-I or somatomedin C) ... the liver. It acts as a potent mitogen ... to specific cell-surface receptors. In the circulation, IGF-I ... to regulate the actions of IGF-I by modulating ...
Urovac bladder evacuator with adaptor...
Medicine Products: